Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. The company is headquartered in Jersey City, New Jersey and currently employs 724 full-time employees. The company went IPO on 2020-06-12. The firm is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.
Mr. Andrew Toy is the Chief Executive Officer of Clover Health Investments Corp, joining the firm since 2018.
What is the price performance of CLOV stock?
The current price of CLOV is $4.86, it has decreased 0.61% in the last trading day.
What are the primary business themes or industries for Clover Health Investments Corp?
Clover Health Investments Corp belongs to Health Care industry and the sector is Health Care
What is Clover Health Investments Corp market cap?
Clover Health Investments Corp's current market cap is $2.5B
Is Clover Health Investments Corp a buy, sell, or hold?
According to wall street analysts, 6 analysts have made analyst ratings for Clover Health Investments Corp, including 2 strong buy, 4 buy, 3 hold, 0 sell, and 2 strong sell